A Day Up For Lisata Therapeutics, Inc.
Wed, Jan 21, 2026 at 07:17 PM
Lisata Therapeutics, Inc. (LSTA:NASDAQ) jumped higher at $4.03, a gain of 86.6%. On Wed, Jan 21, 2026, LSTA:NASDAQ touched a New 2-Week High of $4.03. The stock got featured on our News Catalysts scanner on Wed, Jan 21, 2026 at 08:34 AM in the 'ACQUISITION' category. From Wed, Jan 07, 2026, the stock recorded 44.44% Up Days and 100.00% Green Days
About Lisata Therapeutics, Inc. (LSTA:NASDAQ)
Caladrius Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to the development of treatments and reversal of severe diseases.
Top 10 Gainers:
- Namib Minerals (NAMM:NASDAQ), 130.61%
- Pheton Holdings Ltd (PTHL:NASDAQ), 105.16%
- Global Interactive Technologies, Inc. (GITS:NASDAQ), 97.97%
- PAVmed Inc. (PAVM:NASDAQ), 94.67%
- Lisata Therapeutics, Inc. (LSTA:NASDAQ), 86.57%
- Roma Green Finance Limited (ROMA:NASDAQ), 66.21%
- Smart Logistics Global Limited (SLGB:NASDAQ), 49.59%
- Moolec Science SA (MLEC:NASDAQ), 47.61%
- Boxlight Corporation (BOXL:NASDAQ), 45.6%
- Pineapple Financial Inc. (PAPL:NYSEMKT), 45.36%